Table 1 Baseline characteristics of the patients.
Baseline characteristics | Intervention (n = 5) | Control (n = 5) | P value |
|---|---|---|---|
Age, mean (± SD), years | 48.8 (± 11.4) | 46.0 (± 10.8) | 0.70 |
Race, No./total No. (%) | |||
White | 4/5 (80%) | 4/5 (80%) | 1.00 |
Mixed race | 1/5 (20%) | 1/5 (20%) | 1.00 |
Female, No. /total No. (%) | 4/5 (80%) | 3/5 (60%) | 1.00 |
Time from diagnosis, mean (± SD), months | 25.4 (± 5.2) | 26.0 (± 7.9) | 0.89 |
Type of vasovagal syncope, No. /total no. (%) | |||
Mixed response | 4/5 (80%) | 4/5 (80%) | 1.00 |
Cardioinhibitory | 1/5 (20%) | 0/5 (0%) | 1.00 |
Vasodepressor | 0/5 (0%) | 1/5 (20%) | 1.00 |
Resting ECG, No. /total No. (%) | |||
Normal, Sinus rhythm | 5/5 (100%) | 5/5 (100%) | 1.00 |
Prodromes, No. /total No. (%) | 5/5 (100%) | 5/5 (100%) | 1.00 |
Near-syncope, No. /total No. (%) | 5/5 (100%) | 5/5 (100%) | 1.00 |
History of physical injuries related to syncope | 3/5 (60%) | 2/5 (40%) | 1.00 |
Comorbidities, No. /total No. (%) | |||
Diabetes mellitus | 2/5 (40%) | 1/5 (20%) | 1.00 |
Hypertension | 0/5 (0%) | 1/5 (20%) | 1.00 |
Dyslipidemia | 1/5 (20%) | 1/5 (20%) | 1.00 |
Hypothyroidism | 1/5 (20%) | 0/5 (0%) | 1.00 |
Medications, No. /total No. (%) | |||
Fludrocortisone | 2/5 (40%) | 2/5 (40%) | 1.00 |
Calcium channel blocker (diltiazem) | 0/5 (0%) | 1/5 (20%) | 1.00 |
